BRPI0923191A2 - metodos relacionados com glicanos modificados - Google Patents
metodos relacionados com glicanos modificadosInfo
- Publication number
- BRPI0923191A2 BRPI0923191A2 BRPI0923191A BRPI0923191A BRPI0923191A2 BR PI0923191 A2 BRPI0923191 A2 BR PI0923191A2 BR PI0923191 A BRPI0923191 A BR PI0923191A BR PI0923191 A BRPI0923191 A BR PI0923191A BR PI0923191 A2 BRPI0923191 A2 BR PI0923191A2
- Authority
- BR
- Brazil
- Prior art keywords
- related methods
- modified glycan
- glycan related
- modified
- methods
- Prior art date
Links
- 150000004676 glycans Chemical class 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13922408P | 2008-12-19 | 2008-12-19 | |
| PCT/US2009/068790 WO2010071824A2 (en) | 2008-12-19 | 2009-12-18 | Methods related to modified glycans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0923191A2 true BRPI0923191A2 (pt) | 2016-02-16 |
Family
ID=42269281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0923191A BRPI0923191A2 (pt) | 2008-12-19 | 2009-12-18 | metodos relacionados com glicanos modificados |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9103821B2 (pt) |
| EP (1) | EP2358731B1 (pt) |
| JP (1) | JP2012513030A (pt) |
| CN (1) | CN102239173A (pt) |
| AU (1) | AU2009327435A1 (pt) |
| BR (1) | BRPI0923191A2 (pt) |
| CA (1) | CA2743181A1 (pt) |
| RU (1) | RU2526250C2 (pt) |
| WO (1) | WO2010071824A2 (pt) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| EP2710032B1 (en) | 2011-05-20 | 2019-12-25 | Momenta Pharmaceuticals, Inc. | Modified glycoproteins |
| CN102584728B (zh) * | 2011-12-16 | 2014-06-04 | 北京大学 | 一类基于三嗪结构的糖标记试剂及其合成方法和应用 |
| US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
| US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| WO2014018747A2 (en) | 2012-07-26 | 2014-01-30 | Momenta Pharmaceuticals, Inc. | Glycoproteins with anti-inflammatory properties |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| SG11201507230PA (en) | 2013-03-12 | 2015-10-29 | Abbvie Inc | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US8956830B2 (en) | 2013-03-14 | 2015-02-17 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| EP2991666B1 (en) | 2013-05-02 | 2020-03-25 | Momenta Pharmaceuticals, Inc. | Sialylated glycoproteins |
| US10464996B2 (en) | 2013-05-13 | 2019-11-05 | Momenta Pharmaceuticals, Inc. | Methods for the treatment of neurodegeneration |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| EP3058084A4 (en) | 2013-10-16 | 2017-07-05 | Momenta Pharmaceuticals, Inc. | Sialylated glycoproteins |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| GB201320571D0 (en) | 2013-11-21 | 2014-01-08 | Academisch Ziekenhuis Leiden | Glycan analysis |
| CN104677971B (zh) * | 2013-11-26 | 2017-12-26 | 杭州九源基因工程有限公司 | 一种epo突变体的毛细管电泳检测方法 |
| CN104807927B (zh) * | 2014-01-24 | 2016-08-17 | 中国医学科学院基础医学研究所 | 一种富集唾液酸化糖肽的方法 |
| EP3540071B1 (en) * | 2014-11-19 | 2023-09-06 | Amgen Inc. | Quantitation of glycan moiety in recombinant glycoproteins |
| US9932599B2 (en) | 2015-03-02 | 2018-04-03 | Synthetic Genomics, Inc. | Regulatory elements from labyrinthulomycetes microorganisms |
| US11719704B2 (en) | 2015-12-30 | 2023-08-08 | Momenta Pharmaceuticals, Inc. | Methods related to biologics |
| US10633454B2 (en) | 2016-11-01 | 2020-04-28 | Conagen Inc. | Expression of modified glycoproteins and glycopeptides |
| CN111954713A (zh) * | 2018-03-05 | 2020-11-17 | 科纳根公司 | 用于产生具有低硫酸化的糖分子的生物体和方法 |
| CN108459116B (zh) * | 2018-07-06 | 2021-02-19 | 贵州大学 | 一种荧光高效液相色谱检测发酵红肉制品中Neu5Gc的方法 |
| BR112021006852A2 (pt) | 2018-10-11 | 2021-08-17 | Momenta Pharmaceuticals, Inc. | tratamento com composições de igg altamente sialilada |
| BR112021012973A2 (pt) | 2018-12-31 | 2021-09-14 | Momenta Pharmaceuticals, Inc. | Métodos de produção de ustequinumabe |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| DE19527054A1 (de) | 1995-07-26 | 1997-01-30 | Behringwerke Ag | Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen |
| US6045854A (en) * | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
| PT1522590E (pt) | 2000-06-28 | 2009-10-26 | Glycofi Inc | Métodos para a produção de glicoproteínas modificadas |
| US20060127950A1 (en) * | 2004-04-15 | 2006-06-15 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
| US8039208B2 (en) * | 2005-04-26 | 2011-10-18 | National Institute For Bioprocessing Research And Training Limited (Nibrt) | Automated strategy for identifying physiological glycosylation markers(s) |
| FI20055398A0 (fi) * | 2005-07-08 | 2005-07-08 | Suomen Punainen Risti Veripalv | Menetelmä solupopulaatioiden evaluoimiseksi |
| JP5552231B2 (ja) * | 2005-10-14 | 2014-07-16 | ベリコ メディカル インコーポレイティッド | 血小板の生存延長のための組成物および方法 |
| WO2007061936A2 (en) | 2005-11-18 | 2007-05-31 | New England Medical Center Hospitals, Inc. | Clearance of abnormal iga1 in iga1 deposition diseases |
| AU2007254777B2 (en) * | 2006-06-02 | 2014-02-20 | Robert Sackstein | Compositions and methods for modifying cell surface glycans |
| US8361705B2 (en) | 2007-04-16 | 2013-01-29 | Momenta Pharmaceuticals, Inc. | Characterization of N-glycans using exoglycosidases |
| BRPI0810472A2 (pt) * | 2007-04-16 | 2014-11-11 | Momenta Pharmaceuticals Inc | Métodos relacionados à glicosilação da superfície celular |
-
2009
- 2009-12-18 RU RU2011129747/04A patent/RU2526250C2/ru active
- 2009-12-18 EP EP09833844.5A patent/EP2358731B1/en active Active
- 2009-12-18 CN CN200980147771.0A patent/CN102239173A/zh active Pending
- 2009-12-18 CA CA2743181A patent/CA2743181A1/en not_active Abandoned
- 2009-12-18 AU AU2009327435A patent/AU2009327435A1/en not_active Abandoned
- 2009-12-18 BR BRPI0923191A patent/BRPI0923191A2/pt not_active Application Discontinuation
- 2009-12-18 US US13/140,553 patent/US9103821B2/en active Active
- 2009-12-18 WO PCT/US2009/068790 patent/WO2010071824A2/en not_active Ceased
- 2009-12-18 JP JP2011542496A patent/JP2012513030A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2358731A2 (en) | 2011-08-24 |
| RU2011129747A (ru) | 2013-01-27 |
| US9103821B2 (en) | 2015-08-11 |
| US20110306075A1 (en) | 2011-12-15 |
| AU2009327435A1 (en) | 2010-06-24 |
| EP2358731B1 (en) | 2016-03-09 |
| CA2743181A1 (en) | 2010-06-24 |
| WO2010071824A2 (en) | 2010-06-24 |
| EP2358731A4 (en) | 2012-08-08 |
| RU2526250C2 (ru) | 2014-08-20 |
| WO2010071824A3 (en) | 2010-10-28 |
| JP2012513030A (ja) | 2012-06-07 |
| CN102239173A (zh) | 2011-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0923191A2 (pt) | metodos relacionados com glicanos modificados | |
| PT2813570T (pt) | Resumo | |
| EP3988147C0 (en) | INSERT SET | |
| DK2370462T3 (da) | Glucagon-analoger | |
| DK2342317T3 (da) | Hængende-dråbe-plade | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| EP2258938A4 (en) | TYPE VEHICLE TO BE PROVIDED | |
| PT3045471T (pt) | Resumo | |
| BRPI0914649A2 (pt) | Piprazolo-quinazolinas | |
| DE602008003972D1 (de) | Sitzrücklehnungsmechanismus | |
| DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
| DK2342454T3 (da) | Vindkraftanlæg | |
| DK2336132T3 (da) | Morpholinpurinderivat | |
| DK2335031T3 (da) | In-line-måler | |
| DK2379557T3 (da) | Aminopyrazol-forbindelse | |
| DK2271613T3 (da) | Hydroxymethylcyklohexylaminer | |
| DE602008003970D1 (de) | Strahlstromkalibriersystem | |
| BRPI0911625A2 (pt) | Métodos | |
| EP2257170A4 (en) | TETRAHYDROFUROPYRIDONE | |
| EP2248964A4 (en) | DRILLING / TERMINAL DEVICE | |
| BRPI0907522A2 (pt) | biarlamidas | |
| DE112009000183A5 (de) | Sicherheitsvorreiber | |
| BRPI0909634A2 (pt) | 2-aminoquinolinas | |
| DE602009000862D1 (de) | Gehwagenbremse | |
| EP2245356A4 (en) | STRUCTURAL FIBER STRING, IMPREGNATED WITH RESIN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B09B | Decision: refusal | ||
| B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |